Science & Enterprise subscription

Follow us on Twitter

  • A company developing health metrics with artificial intelligence received a grant to better understand polycystic o… https://t.co/ElPrTv6NfS
    about 11 hours ago
  • New post on Science and Enterprise: Small Biz Grant Funds AI Repro Health Technology https://t.co/kf8kmvP8Xa #Science #Business
    about 11 hours ago
  • The Food and Drug Administration began a pilot program for assessing alternative technologies to test drugs, biolog… https://t.co/r5mRCGGL4B
    about 16 hours ago
  • New post on Science and Enterprise: FDA Begins Qualifying Non-Animal Testing Options https://t.co/pf0GN32FfV #Science #Business
    about 16 hours ago
  • A new enterprise is developing personalized digital therapeutics for people with Alzheimer's disease and other neur… https://t.co/aFxlnK5VHH
    about 1 day ago

Please share Science & Enterprise

Crispr Edits Out HIV-Like Genes from Monkey DNA

Kamel Khalili and Tricia Burdo

Researchers show the gene-editing technique Crispr can remove genes gained from infections similar to HIV in lab monkeys, as well as viral signals from their bodies. . . . → Read More: Crispr Edits Out HIV-Like Genes from Monkey DNA

Engineered Immune, Stem Cells Studied for HIV Cure

HIV released from cell

Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections. . . . → Read More: Engineered Immune, Stem Cells Studied for HIV Cure

FDA Blocks Monthly HIV Drug Combo

T-cell infected by HIV

The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV. . . . → Read More: FDA Blocks Monthly HIV Drug Combo

FDA Approves Single Dual-Drug Pill for HIV

HIV released from cell

The Food and Drug Administration approved a daily pill with 2 drugs to lower viral loads in people with HIV, but who have not yet taken other HIV drugs. . . . → Read More: FDA Approves Single Dual-Drug Pill for HIV

Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Vaginal ring and PrEP

A clinical trial is underway testing use and preferences for drugs or a medical device to prevent HIV infection among young women and teenage girls in Africa. . . . → Read More: Trial Testing Vaginal Ring, PrEP in Teens, Young Women

Patent Set for Long-Term Drug Capsules

Star-shaped drug delivery

Techniques for delivering drugs in capsule form that last a week or longer in the patient are expected to receive a patent soon from U.S. authorities. . . . → Read More: Patent Set for Long-Term Drug Capsules

Infographic – HIV Infections Growing in Eastern Europe

Chart: HIV cases in Europe

While much attention is focused on the continuing AIDS and HIV crisis in Africa, countries in Eastern Europe are also facing growing numbers of HIV infections. . . . → Read More: Infographic – HIV Infections Growing in Eastern Europe

Antibody Combination Shown to Suppress HIV

T-cell infected by HIV

Results from a small-scale clinical trial show a combination of antibodies can suppress the HIV virus for many weeks after stopping antiretroviral therapy. . . . → Read More: Antibody Combination Shown to Suppress HIV

Technique Assessed for Comparing Effectiveness Between Drugs

Analytics

An academic-industry research team validated a statistical technique to evaluate the effectiveness of different drugs treating the same disease, without conducting separate head-to-head clinical trials. . . . → Read More: Technique Assessed for Comparing Effectiveness Between Drugs

HIV Drugs Formulated Into Once-Weekly Capsules

Medical and engineering researchers developed and tested in pigs a technique for packing several drugs into a capsule taken once a week to prevent and treat HIV infections. . . . → Read More: HIV Drugs Formulated Into Once-Weekly Capsules